生命科学资讯

Next-gen CRO Avetra unveils with access to 350-plus US sites

Medtronic's Hugo surgical robot secures US clearance

FDA floats user fee cuts for early-stage US trials, additional fees for overseas development

FDA to name Tracy Beth Høeg, who helped lead Covid-shot investigation, to head CDER

Former FDA commissioners slam Prasad's plan for 'sweeping' vaccine changes

Thermo Fisher Scientific Insider Sold Shares Worth $8,154,131, According to a Recent SEC Filing - MarketScreener

Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy

FDA seeks to raise user fees for companies running Phase 1 trials outside the US

Biologics CDMO Market Trends and Investment Forecast to 2033: Features Analysis of Lonza Group, Cata - PharmiWeb.com

FDA says it won't release details of claimed Covid vaccine deaths in 'near term'

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis

Appointments and advancements for Dec. 3, 2025

Financings for Dec. 3, 2025

In the clinic for Dec. 3, 2025

Other news to note for Dec. 3, 2025

Regulatory actions for Dec. 3, 2025

With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection

Black Diamond reports mid-stage lung cancer data, continues its hunt for a partner

Capricor soars on positive results for Duchenne cell therapy